Related Experiment Video
Updated: Jun 9, 2026

06:09
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
14-3-3 proteins are promising LRRK2 interactors
Iakov N Rudenko1, Mark R Cookson
1Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD 20982-3707, USA.
The Biochemical Journal
|August 28, 2010
Summary
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause familial Parkinson's disease (PD). Researchers found LRRK2 interacts with 14-3-3 proteins, potentially stabilizing LRRK2 and offering new therapeutic avenues for PD.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most frequent genetic cause of familial Parkinson's disease (PD).
- LRRK2 contains catalytic domains (GTPase, kinase) and poorly understood protein-protein interaction domains.
- 14-3-3 proteins are regulatory molecules that bind phosphorylated signaling pathway components.
Purpose of the Study:
- To investigate the interaction between the N-terminal region of LRRK2 and 14-3-3 proteins.
- To identify specific residues in LRRK2 responsible for 14-3-3 binding.
- To understand the functional implications of this interaction on LRRK2 structure and cellular distribution.
Main Methods:
- Combination of biochemical techniques.
- Identification of specific serine residues (Ser910 and Ser935) crucial for 14-3-3 binding.
- Correlation of 14-3-3 binding with intracellular LRRK2 distribution patterns.
Main Results:
- Identified Ser910 and Ser935 as critical for LRRK2 binding to 14-3-3 proteins.
- Demonstrated that 14-3-3 binding can prevent dephosphorylation of Ser910/Ser935.
- Observed that 14-3-3 interaction may stabilize LRRK2 structure, potentially through influencing dimerization.
- Found a correlation between 14-3-3 binding and the intracellular localization of LRRK2.
Conclusions:
- The interaction between LRRK2 and 14-3-3 proteins represents a significant regulatory mechanism for LRRK2.
- This interaction may stabilize LRRK2 structure and influence its cellular function.
- Understanding this mechanism could lead to novel therapeutic strategies for Parkinson's disease.
More Related Videos
Related Concept Videos
Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
Assembly of Signaling Complexes
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Protein Networks
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.

